T56-LIMKi - T5601640

Based on 14 reference(s) in Google Scholar 10 10 14

Axon 2721

CAS [924473-59-6]

MF C19H14F3N3O3
MW 389.33

  • Purity: 99%
  • Soluble in DMSO

T56-LIMKi

Description

T56-LIMKi is an inhibitor of LIMK2. T56-LIMKi efficiently inhibited the growth of NF1-/- MEF, ST88-14, U87, and Panc-1 cells with IC50 values of 30 μM, 18 μM, 7 μM, and 35 μM, respectively. Moreover, T56-LIMKi reduced tumor size and p-cofilin levels in the Panc-1 tumors in vivo. Potential drug for pancreatic cancer, glioma and schwannoma cells.

KEYWORDS: T56-LIMKi | supplier | LIMK2 inhibitor | T5601640 | T56 LIMKi | T56LIMKi | T 5601640 | T-5601640 | CAS [924473-59-6] | Non Selective (ADF-cofilin) | LIMK2 | Inhibitor | Enzymes | LIM | LIM kinase | cofilin | ADF | Panc-1

Order
Size Unit Price Stock
10 mg €125.00 In Stock
50 mg €450.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...